Literature DB >> 32338439

Black Phosphorus Quantum Dots Cause Nephrotoxicity in Organoids, Mice, and Human Cells.

Chengyong He1, Fengkai Ruan1,2, Shengwei Jiang3, Jie Zeng1, Hanying Yin1, Rong Liu2, Yongxing Zhang2, Laiqiang Huang3, Chonggang Wang1, Shaohua Ma3, Zhenghong Zuo1.   

Abstract

Quantum dots (QDs) have numerous potential applications in lighting, engineering, and biomedicine. QDs are mainly excreted through the kidney due to their ultrasmall sizes; thus, the kidneys are target organs of QD toxicity. Here, an organoid screening platform is established and used to study the nephrotoxicity of QDs. Organoids are templated from monodisperse microfluidic Matrigel droplets and found to be homogeneous in both tissue structure and functional recapitulation within a population and suitable for the quantitative screening of toxic doses. Kidney organoids are proved displaying higher sensitivity than 2D-cultured cell lines. Similar to metal-containing QDs, black phosphorus (BP)-QDs are found to have moderate toxicity in the kidney organoids. The nephrotoxicity of BP-QDs are validated in both mice and human renal tubular epithelial cells. BP-QDs are also found to cause insulin insensitivity and endoplasmic reticulum (ER) stress in the kidney. Furthermore, ER stress-related IRE1α signaling is shown to mediate renal toxicity and insulin insensitivity caused by BP-QDs. In summary, this work demonstrates the use of constructed kidney organoids as 3D high-throughput screening tools to assess nanosafety and further illuminates the effects and molecular mechanisms of BP-QD nephrotoxicity. The findings will hopefully enable improvement of the safety of BP-QD applications.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  black phosphorus; kidney; nanosafety assessment; organoids; quantum dots

Mesh:

Substances:

Year:  2020        PMID: 32338439     DOI: 10.1002/smll.202001371

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  7 in total

1.  Acute and Subacute Safety Evaluation of Black Tea Extract (Herbt Tea Essences) in Mice.

Authors:  Xiaoyan Ding; Changshun Han; Weiping Hu; Chengqing Fu; Yixi Zhou; Zheng Wang; Qingyan Xu; Rongfu Lv; Chengyong He; Zhenghong Zuo; Jiyi Huang
Journal:  Toxics       Date:  2022-05-27

Review 2.  Kidney organoids as a promising tool in nephrology.

Authors:  Mengyuan Wu; Tingting Hu; Ping Zhu; Moussa Ide Nasser; Jie Shen; Fang Sun; Qingnan He; Mingyi Zhao
Journal:  Genes Dis       Date:  2021-01-30

3.  Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids.

Authors:  Lisi Zeng; Quanxing Liao; Quanxing Zhao; Shengwei Jiang; Xianzi Yang; Hongsheng Tang; Qingjun He; Xiansheng Yang; Shuxian Fang; Jinfu He; Weiwen Cui; Laiqiang Huang; Shaohua Ma; Shuzhong Cui
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

Review 4.  Nanoparticle-Induced m6A RNA Modification: Detection Methods, Mechanisms and Applications.

Authors:  Yi Wang; Fengkai Ruan; Zhenghong Zuo; Chengyong He
Journal:  Nanomaterials (Basel)       Date:  2022-01-25       Impact factor: 5.076

Review 5.  Recent advances in the biomedical applications of black phosphorus quantum dots.

Authors:  Yuhang Miao; Xiaojing Wang; Jie Sun; Zhong Yan
Journal:  Nanoscale Adv       Date:  2021-01-26

6.  Noninvasive Dual-Modality Photoacoustic-Ultrasonic Imaging to Detect Mammalian Embryo Abnormalities after Prenatal Exposure to Methylmercury Chloride (MMC): A Mouse Study.

Authors:  Qi Qiu; Yali Huang; Bei Zhang; Doudou Huang; Xin Chen; Zhongxiong Fan; Jinpei Lin; Wensheng Yang; Kai Wang; Ning Qu; Juan Li; Zhihong Li; Jingyu Huang; Shenrui Li; Jiaxing Zhang; Gang Liu; Gang Rui; Xiaoyuan Chen; Qingliang Zhao
Journal:  Environ Health Perspect       Date:  2022-02-02       Impact factor: 9.031

Review 7.  Application Progress of Organoids in Colorectal Cancer.

Authors:  Lianxiang Luo; Yucui Ma; Yilin Zheng; Jiating Su; Guoxin Huang
Journal:  Front Cell Dev Biol       Date:  2022-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.